Verrica Pharmaceuticals Inc. Annual Operating Income (Loss) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Verrica Pharmaceuticals Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2017 to 2023.
  • Verrica Pharmaceuticals Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$20.7M, a 13.4% increase year-over-year.
  • Verrica Pharmaceuticals Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$77.6M, a 59% decline year-over-year.
  • Verrica Pharmaceuticals Inc. annual Operating Income (Loss) for 2023 was -$65.8M, a 209% decline from 2022.
  • Verrica Pharmaceuticals Inc. annual Operating Income (Loss) for 2022 was -$21.3M, a 31.1% increase from 2021.
  • Verrica Pharmaceuticals Inc. annual Operating Income (Loss) for 2021 was -$30.9M, a 23.1% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$65.8M -$44.5M -209% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 -$21.3M +$9.61M +31.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 -$30.9M +$9.27M +23.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-06
2020 -$40.2M -$10.1M -33.6% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-02
2019 -$30.1M -$8.2M -37.5% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-17
2018 -$21.9M -$17.4M -391% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-13
2017 -$4.46M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.